Tavexia Lifecare Ltd has disclosed information under Regulation 29(2) of SEBI regarding a substantial acquisition of…
India — direction and magnitude withheld
Direction and magnitude are withheld for India-region stories. Named companies below are shown without any directional call or impact magnitude; the omission is deliberate, not missing data. This intelligence is provided for informational purposes only. Branch² is not a SEBI-registered research analyst. This is not investment advice. Past performance is not indicative of future results. Please consult a SEBI-registered investment adviser before making any investment decision. Users must comply with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Key takeaway
Roshan Dealmark Pvt Ltd and its PAC have made a substantial acquisition in Tavexia Lifecare Ltd, triggering SEBI SAST Regulation 29(2) disclosure.
- Step 1 · The triggerRoshan Dealmark Pvt Ltd and its PAC acquire a substantial stake in Tavexia Lifecare Ltd, triggering SEBI SAST Regulation 29(2) disclosure
- Step 2 · Knock-onIf the shareholding crosses the open offer threshold, Roshan Dealmark may be required to make a mandatory open offer, increasing its influence over Tavexia's board and strategy
- Step 3 · Reaches youA change in control or board composition at Tavexia Lifecare Ltd could lead to renegotiation or review of supplier, distributor, or service contracts, impacting SMEs with exposure
The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.
Source: BSE
See what today’s news does to your business. Atri by Branch² — Early-warning intelligence for your businessThis is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.